Tenax Therapeutics (TENX) Equity Ratio (2011 - 2026)
Tenax Therapeutics recorded quarterly Equity Ratio of 0.93 in Q1 2026, little changed quarter-over-quarter from 0.93 in Q4 2025, and down 4.53% year-over-year from 0.98 in Q1 2025.
Tenax Therapeutics' Equity Ratio history runs 15 years deep, the most recent figure standing at 0.93 for Q1 2026.
- In Q1 2026, Equity Ratio fell 4.53% year-over-year to 0.93; the TTM figure through Mar 2026 stood at 0.93 (down 4.53% YoY), while the FY2025 annual figure was 0.93, down 2.11% from the prior year.
- Equity Ratio came in at 0.93 for Q1 2026 at Tenax Therapeutics, roughly flat from 0.93 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.98 in Q2 2025 to a low of 0.43 in Q1 2022.
- A 5-year average of 0.85 and a median of 0.93 in 2025 frame the typical range for Equity Ratio.
- Across the five-year window, Equity Ratio sank 38.1% in 2022 and soared 117.56% in 2023, its largest moves.
- Tenax Therapeutics' Equity Ratio stood at 0.44 in 2022, then soared by 58.04% to 0.69 in 2023, then jumped by 37.29% to 0.95 in 2024, then fell by 2.11% to 0.93 in 2025, then declined by 0.03% to 0.93 in 2026.
- According to Business Quant data, Equity Ratio over the past three periods registered 0.93, 0.93, and 0.94 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.21 |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | 0.93 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.93 |
| Dec 31, 2025 | 0.93 |
| Sep 30, 2025 | 0.94 |
| Jun 30, 2025 | 0.98 |
| Mar 31, 2025 | 0.98 |
| Dec 31, 2024 | 0.95 |
| Sep 30, 2024 | 0.97 |
| Jun 30, 2024 | 0.84 |
| Mar 31, 2024 | 0.86 |
| Dec 31, 2023 | 0.69 |
| Sep 30, 2023 | 0.95 |
| Jun 30, 2023 | 0.94 |
| Mar 31, 2023 | 0.93 |
| Dec 31, 2022 | 0.44 |
| Sep 30, 2022 | 0.83 |
| Jun 30, 2022 | 0.81 |
| Mar 31, 2022 | 0.43 |
| Dec 31, 2021 | 0.71 |
| Sep 30, 2021 | 0.81 |
| Jun 30, 2021 | 0.51 |
| Mar 31, 2021 | 0.68 |
| Dec 31, 2020 | 0.67 |
| Sep 30, 2020 | 0.82 |
| Jun 30, 2020 | 0.57 |
| Mar 31, 2020 | 0.57 |
| Dec 31, 2019 | 0.59 |
| Sep 30, 2019 | 30.86 |
| Jun 30, 2019 | 0.00 |
| Mar 31, 2019 | 0.00 |
| Dec 31, 2018 | 0.88 |
| Sep 30, 2018 | 0.90 |
| Jun 30, 2018 | 0.89 |
| Mar 31, 2018 | 0.96 |
| Dec 31, 2017 | 0.90 |
| Sep 30, 2017 | 0.92 |
| Jun 30, 2017 | 0.84 |
| Mar 31, 2017 | 0.74 |
| Dec 31, 2016 | 0.73 |
| Sep 30, 2016 | 0.78 |
| Jun 30, 2016 | 0.79 |
| Dec 31, 2015 | 0.83 |
| Apr 30, 2013 | -0.56 |
| Jan 31, 2013 | -0.53 |
| Oct 31, 2012 | -0.02 |
| Jul 31, 2012 | -0.12 |
| Apr 30, 2012 | -0.08 |
| Jan 31, 2012 | -0.15 |
| Oct 31, 2011 | -0.82 |
| Jul 31, 2011 | -0.26 |
| Apr 30, 2011 | -1.27 |